Bank of America
AMED

Bank of America’s Amedisys AMED Stock Holding History

Bank of America’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-52,500
Closed -$3.86M – 7691
2023
Q1 		$3.86M Buy
+52,500
New +$4.54M ﹤0.01% 3766
2013
Q3 		– Sell
-86,900
Closed -$1.01M – 7851
2013
Q2 		$1.01M Buy
+86,900
New +$995K ﹤0.01% 4020

Other funds holding AMED

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MCI
MRP Capital Investments Alpharetta, Georgia $136M AUM 59.34% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Bank of America's AMED Position: Q3 2025 in Review

Bank of America sold out of Amedisys (AMED) in Q3 2025, closing a stake of 454,519 shares — an estimated $44.7M sold.

Bank of America first reported a position in AMED in Q2 2013 and held it in 49 quarters. The position peaked at $122M in Q4 2020. 4 funds tracked by Wall St. Rank hold AMED as of Q3 2025.

  • Bank of America reported no remaining Amedisys position as of Q3 2025 after selling out during the quarter.
  • Bank of America sold 454,519 Amedisys shares in Q3 2025, an estimated $44.7M.
  • Bank of America first reported a position in Amedisys in Q2 2013 and held it in 49 quarters.
  • Bank of America's Amedisys position peaked at $122M in Q4 2020.
  • 4 funds tracked by Wall St. Rank held Amedisys as of Q3 2025.

Based on Bank of America's 13F filing for Q3 2025, filed 14 Nov 2025.